Larry Lands

Larry Lands, MD, PhD is a Professor in the Department of Pediatrics, Faculty of Medicine and Health Sciences at McGill University and a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC), Glen site. He leads the Translational Research in Respiratory Diseases Program within the Centre for Translational Biology, focusing on chronic pediatric lung diseases.

Research Interests

• Clinical & Translational Research: Investigating cystic fibrosis, primary ciliary dyskinesia, and severe asthma in children.
• Novel Therapeutics: Developing inhalable nucleic acid and small-molecule therapies to control lung inflammation and repair airway damage.
• Exercise Physiology: Examining factors limiting exercise capacity in adolescents with obesity and other at-risk populations.
• Diagnostic Innovation: Pioneering oscillometry as a simple, child-friendly lung-function assessment tool for infants and children.

Recent Research Trends
His 2024–2025 publications reveal an intensified focus on cutting-edge CFTR modulator trials (e.g., elexacaftor-tezacaftor-ivacaftor comparisons), mucolytic microsphere therapies (CIL-05), and the first Canadian clinical practice guidelines on cystic-fibrosis-related diabetes. Additional work explores lung ultrasound for PCD/CF, post-lung-transplant weight dynamics, and spectral oscillometry in obese adolescents, underscoring a translational pipeline from bench to bedside.

Scientific Awards & Honors
No specific awards are listed in the provided text.

Advising & Grant Activity
While specific trainees and grants are not enumerated, his role as Senior Scientist and Professor implies active mentorship of graduate students, clinical fellows, and post-docs within the RI-MUHC and McGill University ecosystems.

Labs & Teams
He heads the Translational Research in Respiratory Diseases Program at the RI-MUHC, integrating bench scientists, clinical coordinators, and imaging specialists to advance pediatric respiratory medicine.